Skip to main content
main-content

Primary care

04-01-2022 | DUKPC 2022 | Conference coverage | News

CVD-focused SGLT2 inhibitor prescribing failing to take hold

The proven cardiovascular benefits of SGLT2 inhibitors has not led doctors to prioritize their use in people at high risk, show findings from UK general practice.

03-30-2022 | Healthcare systems | News

Continuity of care linked to reduced CVD risk among people with diabetes

Increased team-based continuity of care correlates with decreased risk for cardiovascular disease in people with type 2 diabetes, researchers report in Diabetes Care.

02-04-2022 | Non-alcoholic fatty liver disease | News

Doctors call for NAFLD care pathway in type 2 diabetes

Physicians feel that nonalcoholic fatty liver disease is sidelined in type 2 diabetes management and should be formally incorporated into routine primary care pathways, say Australian researchers.

01-25-2022 | Type 2 diabetes | News

Shift toward specialist care for type 2 diabetes

UK researchers find people with type 2 diabetes are increasingly being cared for in specialist settings, rather than by family doctors.

11-02-2021 | Type 2 diabetes | News

One in 20 may achieve type 2 diabetes remission in routine care

Researchers have found evidence that almost one in 20 people diagnosed with type 2 diabetes in routine clinical care later achieve remission.

06-04-2021 | ATTD 2021 | Conference coverage | News

‘Smart’ questionnaire could refocus diabetes consultations

Completing a brief, adaptive questionnaire prior to each consultation with healthcare providers can focus discussions toward the immediate priorities and concerns of people with diabetes, shows a feasibility study.

05-11-2021 | Primary care | News

Primary care processes tied to CV risk in people with type 2 diabetes

People with type 2 diabetes receiving care from a general practitioner with low adherence to recommended follow-up procedures have higher risk for cardiovascular disease and poor glycemic control than those registered with high-performing general practitioners, suggest results from the ROSA 4 study.

03-15-2021 | Risk factors | News

Clinicians slow to address CV risk factors in type 2 diabetes

People with type 2 diabetes, particularly those diagnosed at a young age, can face an extended wait for medication to treat cardiovascular risk factors, even if they are in a high-risk category, research shows.

Related topics

Superior

Related